MedPath

Analysis of the Molecular Profile of the Mixofibrosarcoma of the Extremities

Completed
Conditions
Sarcoma,Soft Tissue
Registration Number
NCT04991883
Lead Sponsor
Istituto Ortopedico Rizzoli
Brief Summary

Single institution case series review with a histological diagnosis of mixofibrosarcoma of the extremities from 01 Jan 1993 to 01 Dec 2017.

The study will exam all the clinical, radiological, histological and immunohistochemical features of this tumour in all samples and in a limited serie of cases the presence of mutation of 50 genes cancer related.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
167
Inclusion Criteria
  1. Male and female patients treated at Rizzoli Institute from 01 Jan 1993 to 01 Dec 2017
  2. Diagnosis of mixofibrosarcoma of extremities
  3. Histological slides/formalin-fixed paraffin-embedded tissue tumor (FFPE) blocks from archive available to perform the histology analysis and molecular analysis
  4. Enough tumor biobanked material available for molecular analysis
  5. Presence of the biobank signed informed consent
  6. Written informed consent prior to any study-specific analysis and/or data collection
Exclusion Criteria
  1. Patients with histological diagnosis different from mixofibrosarcoma of extremities

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
disease-free survivalat baseline (Day0)

identify patients with different risk classes in terms of disease-free survival (local and systemic recurrence).

overall survivalat baseline (Day0)

identify patients with different risk classes in terms of overall survival.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Istituto Ortopedico Rizzoli

🇮🇹

Bologna, BO, Italy

© Copyright 2025. All Rights Reserved by MedPath